Plasma methylmalonate and homocysteine: metabolic markers of vitamin deficiency;P-metylmalonat og P-homocystein: Metaboliske markører for Vitaminmangel - Om analysernes baggrund, validitet og applikationer

Ugeskrift for Laeger

Volumn 158, Issue 27, 1996, Pages 3913-3918

  Rasmussen, Karsten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; HOMOCYSTEINE; METHYLMALONIC ACID;

BLOOD; BLOOD ANALYSIS; CHEMISTRY; CYANOCOBALAMIN DEFICIENCY; EVALUATION; FOLIC ACID DEFICIENCY; HUMAN; METHODOLOGY; PYRIDOXINE DEFICIENCY; REVIEW; STANDARD; VITAMIN DEFICIENCY;

AMINO ACIDS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; EVALUATION STUDIES; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; METHYLMALONIC ACID; VITAMIN B 12 DEFICIENCY; VITAMIN B 6 DEFICIENCY; VITAMIN B DEFICIENCY;

EID: 0030194573     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Nexø E. International conference on homocysteinc metabolism. From basic science to clinical medicine. Ugeskr Læger 1995; 157: 5560.
2. Rasmussen K, Vyberg B, Pederscn KO, Brøchner-Mortensen J. Methylmalonic acid in renal insufficiency: Evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990; 36: 1523-4.
3. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993; 39: 1764-79.
4. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991; 29: 549-54.
5. Møller J, Rasmussen K. Homocysteine in plasma: stabilisation of blood samples with fluoride. Clin Chem 1995; 41: 758-9.
6. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989; 35. 260-4.
7. Rasmussen K, Møller J, Lyngbak M, Pedersen AH, Dybkjær L. Age and gender specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996; 42: 630-1.
8. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 1993; 7: 1344-53.
9. Rasmussen K. Studies on methylmalonic acid in humans. I. Concentrations in serum and urinary excretion in normal subjects after feeding and during fasting, and after loading with protein, fat, sugar, isoleucine, and valine. Clin Chem 1989; 35: 2271-6.
10. Rasmussen K, Møller J, Østergaard K, Kristensen MØ, Jensen J. Methylmalonic acid concentrations in serum of normal subjects: biological variability and effect of oral Lisoleucine loads before and after intramuscular administration of cobalamin. Clin Chem 1990; 36: 1295-9.
11. Ubbink JB, Becker PJ, Vermaak WJH, Delport R. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995; 41: 1033-7.
12. Mølby L, Rasmussen K, Rasmussen HH. Serum methylmalonic acid in uraemia. Scand J Clin Invest 1992; 52: 351-4.
13. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990; 34: 99-107.
14. Hagelskjær L, Rasmussen K. Methylmalonic acid concentration in serum not affected in hepatic disease. Clin Chem 1992; 38: 493-5.
15. Hagelskjær L, Rasmussen K, Pedersen KO. Patients with human immunodeficiency virus infection have normal concentration of methylmalonic acid in serum [letter]. Am J Hematol 1991; 37:139.
16. Rasmussen K, Nathan E. The clinical evaluation of cobalamin deficiency by determination of methylmalonic acid in serum or urine is not invalidated by the presence of heterozygous methylmalonic-acidaemia. J Clin Chem Clin Biochem 1990; 28: 419-21.
17. Malinow MR. Plasma homocyst(c)inc and arterial occlusive diseases: a mini-review. Clin Chem 1995; 41: 173-6.
18. Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40: 230-5.
19. Andersson A, Hultberg B, Brattström L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992; 30: 377-9.
20. Brynskov J, Andersen K, Gimsing P, Hippe E. False low serum vitamin B12 values with radiodilution assays using blocked R-binders [letter]. Lancet 1983; I: 1104-5.
21. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239-46.
22. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990; 34: 90-8.
23. Rasmussen K, Pedersen KO, Mortensen ES, Mølby L, Jensen MK. Laboratoriediagnostik af cobalaminmangel. Ugeskr Læer 1992; 154: 326-30.
24. Nexø E, Hansen M, Rasmussen K, Lindgren A, Gräsbeck R. How to diagnose cobalamin deficiency. Scand J Clin lab Invest 1994; 54 (suppl 219): 61-76.
25. Nilsson-Ehle H, Landahl S, Lindstedt G, Netterblad L, Stochbruegger R, Westin J et al. Low serum cobalamin levels in a population study of 70-and 75-year-old subjects. Gastrointestinal causes and hematological effects. Dig Dis Sci 1989; 34: 716-23.
26. Pennypacker LC, Allen RH, Kelly JP. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992; 40: 1197-204.
27. Carmel R. Subtle and atypical cobalamin deficiency states. Am J Hematol 1990; 34: 108-14.
28. Lindenbaum J, Healton EB, Savage DG et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis.. N Engl J Med 1988; 318: 1720-8.
29. Ubbink JB, Vermaak WJH, Van der Mcrwe A, Becker P. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993; 57: 47-53.
30. Stampfer MJ, Willett WC. Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake [editorial]. JAMA 1993; 270: 2726-7.
31. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-8.
32. Jørgensen LM, Kirchhoff M, Schulz-Larsen K, Schroll M. Danskernes kostvaner beskrevet ved hjælp af syvdages kostskemaer. III. Indtagelsen af vitaminer, mineraler og sporstoffer. Scand J Nutr/Näringsforskning 1992; 36: 8-11.
33. Stampfer MJ, Malinow MR Can lowering homocysteine levels reduce cardiovascular risk? [editorial]. N Engl J Med 1995; 332: 328-9.
34. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
35. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993; 71: 337-59.
36. Malinow MR, Stampfer MJ. Role of plasma homocyst(e)ine in arterial occlusive diseases [editorial]. Clin Chem 1994; 40: 857-8.
37. Selhub J, Jaques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286-91.
38. Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR et al. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem 1994; 40: 552-61.
39. Ubbink JB, Vermaak WJH, Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994; 124: 1927-33.
40. Nexø E. Vitaminer mod hjerte-kar-sygdom? Ugeskr Læger 1994; 156: 3785-6.